HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
11.99
-0.05 (-0.42%)
May 22, 2026, 4:00 PM EDT - Market closed
HUTCHMED (China) Market Cap
HUTCHMED (China) has a market cap or net worth of $2.05 billion as of May 22, 2026. Its market cap has decreased by -18.96% in one year.
Market Cap
2.05B
Enterprise Value
798.02M
1-Year Change
-18.96%
Ranking
Category
Stock Price
$11.99
Market Cap Chart
Since March 17, 2016, HUTCHMED (China)'s market cap has increased from $1.60B to $2.05B, an increase of 28.60%. That is a compound annual growth rate of 2.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 2.09B | -10.03% |
| Dec 31, 2025 | 2.33B | -7.42% |
| Dec 31, 2024 | 2.51B | -19.95% |
| Dec 29, 2023 | 3.14B | 22.75% |
| Dec 30, 2022 | 2.56B | -50.05% |
| Dec 31, 2021 | 5.12B | 19.79% |
| Dec 31, 2020 | 4.27B | 27.79% |
| Dec 31, 2019 | 3.34B | 8.92% |
| Dec 31, 2018 | 3.07B | -35.89% |
| Dec 29, 2017 | 4.79B | 195.91% |
| Dec 30, 2016 | 1.62B | 1.27% |
| Mar 17, 2016 | 1.60B | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Supernus Pharmaceuticals | 2.87B |
| Prestige Consumer Healthcare | 2.28B |
| BioCryst Pharmaceuticals | 2.13B |
| Bausch Health Companies | 2.04B |
| ANI Pharmaceuticals | 1.76B |
| Perrigo Company | 1.57B |
| Amylyx Pharmaceuticals | 1.55B |
| Phibro Animal Health | 1.36B |